Webcast/CME - Importance of Assessing Immunocompetence in Biologic Drug Development

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Bacterial Infections

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Bacterial Infections

	Drug-Resistant TB
	Peritoneal Tuberculosis: Modern Peril for an Ancient Disease
	Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies
	Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies

Recent news - Bacterial Infections

	TopAbstracts in Bacterial Infections 11/23/2009 - (DGNews)
	Genotypes of Patients With Helicobacter pylori Infection May be More Associated With Related Gastric Diseases Than Variants: Presented at ASCP - (DGDispatch)
	TopAbstracts in Bacterial Infections 11/09/2009 - (DGNews)
	Methicillin-Resistant Staphylococcus aureus Strain Linked to High Mortality Rates: Presented at IDSA - (DGDispatch)
	Study Examines Associations Between Antibiotic Use During Pregnancy, Birth Defects - (DGNews)

Recent cases - Bacterial Infections

	Something Fishy
	Renal Amyloidosis in Whipple Disease: A Case Report
	A 72-Year-Old Man with a Rapidly Progressive Sepsis Caused by a Rare But Life-Threatening Infection
	A Rare Case of Cervical Tuberculosis Simulating Carcinoma Cervix: A Case Report
	Primary Tubercular Liver Abscess in an Immunocompetent Adult: A Case Report

personal edition > bacterial infections > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Importance of Assessing Immunocompetence in Biologic Drug Development

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	Leonard H. Calabrese, DO
Approximate duration:	30 mins.
Summary points:	This audiovisual presentation defines immunocompetence and cites the issues associated with its assessment, provides examples of various opportunistic infections associated with biologic therapies, and identifies the role of preclinical immunological and genetic models in assessing immunocompetence.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s). Expiration Date: February 5, 2010.
Other:

Additional Information